Liver Injury Is Most Commonly Due to Hepatic Metastases Rather Than Drug Hepatotoxicity During Pembrolizumab Immunotherapy

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15413

Related search